|1.||Kuge, Tomoo: 3 articles (10/2004 - 03/2003)|
|2.||Willett, Michael S: 2 articles (10/2004 - 03/2003)|
|3.||Shibata, Takashi: 2 articles (10/2004 - 03/2003)|
|4.||Inoue, Masayasu: 1 article (09/2012)|
|5.||Sato, Eisuke F: 1 article (09/2012)|
|6.||Kobayashi, Hiromi: 1 article (09/2012)|
|7.||Hiramoto, Keiichi: 1 article (09/2012)|
|8.||Yamate, Yurika: 1 article (09/2012)|
|9.||Miura, Takanori: 1 article (09/2012)|
|10.||Ishii, Masamitsu: 1 article (09/2012)|
07/01/2003 - "The results suggest that Seirogan may be an effective therapy for patients with stress-associated diarrhea."
03/01/2003 - "Seirogan, an herbal medicine containing wood creosote (CAS 8021-39-4), a mixture of simple phenolic compounds, has been marketed for the past century in Asia for the treatment of acute diarrhea and associated symptoms, such as abdominal discomfort and cramping. "
10/01/2004 - "Multicenter, double-blind, randomized comparison of wood creosote, the principal active ingredient of Seirogan, an herbal antidiarrheal medication, and loperamide in adults with acute nonspecific diarrhea."
09/01/2001 - "Seirogan, an herbal medicine containing wood creosote (tablets, 10.0% w/w), has been developed and marketed for almost a century in various countries for the control of acute diarrhea and treatment of associated symptoms, such as abdominal cramping. "
07/01/2011 - "We report two cases of Anisakiasis, the symptoms of which were ameliorated after the administration of an over-the-counter (OTC) medicine containing wood creosote (Seirogan). "
07/01/2011 - "Two cases of gastric Anisakiasis for which oral administration of a medicine containing wood creosote (Seirogan) was effective."
09/01/2012 - "Effect of the smell of Seirogan, a wood creosote, on dermal and intestinal mucosal immunity and allergic inflammation."
09/01/2012 - "The sensitization of mice with either FITC or oxazolone markedly increased the plasma levels of tumor necrosis factor-α and mucosal IgA and elicited severe inflammation in the colon by a mechanism that could be suppressed by exposure of animals to the smell of uncoated Seirogan as effectively as the oral administration of the agent. "
|4.||Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
|7.||Immunoglobulin A (IgA)